Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brigitte C Widemann
COG Phase I Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital for Sick Children
Toronto, Ontario, Canada
- Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, Canada
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Lurie Children'S Hospital-Chicago
Chicago, Illinois, United States
- Indiana University/melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Riley Hospital for Children
Indianapolis, Indiana, United States
- National Institutes of Health Clinical Center
Bethesda, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- C S Mott Children'S Hospital
Ann Arbor, Michigan, United States
- University of Minnesota/masonic Cancer Center
Minneapolis, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Columbia University/herbert Irving Cancer Center
New York, New York, United States
- State University of New York Upstate Medical University
Syracuse, New York, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh of Upmc
Pittsburgh, Pennsylvania, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Ut Southwestern/simmons Cancer Center-Dallas
Dallas, Texas, United States
- Baylor College of Medicine/dan L Duncan Comprehensive Cancer Center
Houston, Texas, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
- Children'S Hospital of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 May 2006
- Primary completion
- 16 Mar 2012
- Completion
- 10 Dec 2012
- Last update posted
- 2 Feb 2021
- Registered enrollment
- 70
- Registry id
- NCT01445080
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.